Goldstein Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Goldstein Advisors's BIIB Position: Q3 2026 in Review
Goldstein Advisors opened a new position in Biogen (BIIB) in Q3 2026: 932 shares worth $211K. The stake represents 0.02% of the portfolio and ranks #249 among its holdings.
1,062 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Goldstein Advisors held 932 shares of Biogen worth $211K as of Q3 2026.
- Biogen was a new Goldstein Advisors position in Q3 2026.
- Biogen made up 0.02% of Goldstein Advisors's portfolio in Q3 2026, its #249 holding.
- 1,062 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Goldstein Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.